Related Experiment Videos
Neuroprotection in PD--a role for dopamine agonists?
1University Department of Clinical Neurosciences, Royal Free and University College Medical School, and Institute of Neurology, UCL, London, United Kingdom.
Neurology
|September 25, 2003
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Combined assessment of blood glucocerebrosidase activity and α-synuclein levels in GBA1 mutation carriers: A novel potential biomarker.
Parkinsonism & related disorders·2025
Levodopa-carbidopa intestinal gel infusion (LCIG) in Parkinson disease with genetic mutations.
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2023
Genetic causes of PD: A pathway to disease modification.
Neuropharmacology·2020
Parkinson disease.
European journal of neurology·2019
Neurological effects of glucocerebrosidase gene mutations.
European journal of neurology·2018
Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy.
Movement disorders : official journal of the Movement Disorder Society·2017
Effectiveness and Safety of Spesolimab in Adolescents and Adults with Generalized Pustular Psoriasis.
Pragmatic and observational research·2026
Preclinical Evaluation of Anti-Acne Topical Creams Containing Psorospermum Febrifugum Stem Bark Extract: Lipase Inhibition, Sebum Regulation, and Dermal Safety.
Clinical, cosmetic and investigational dermatology·2026
Impact of Hydrogel Spacer on Radiation Proctitis After Prostate Cancer Radiation Therapy: A Large-Scale Claims Database Analysis.
Advances in radiation oncology·2026
Discovery of a Potent and Selective KRAS G12D Degrader based on PROTAC Degradation.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences·2026